Funding News

Opto Health, a London-based developer of digital triage software for emergency care, has secured £544.3k in its latest funding round. Founded in 2022, the company provides a clinically-validated platf...

Altrincham-based Cytospire Therapeutics has secured £3.4m in Series A funding to advance its development of next-generation multispecific antibodies. The company focuses on pan-gamma delta T cell enga...

The development of well-being and stimulation products is the core focus of The Water Street Collective Limited, which has just secured an estimated £10.7m in new funding. Based in London, the company...

Developing an implanted Electric Field Therapy device to treat glioblastoma, Nether Alderley-based Qv Bioelectronics has secured an estimated £100k in new funding. The company, which was incorporated ...

Targeting the preventative health market, Muto Longevity Limited has raised an estimated £50k to support the production of its clinical-grade longevity nutraceuticals. Based in Bolton, the company man...

Developing blood-based tests for early liver cancer detection, Cambridge-based Mursla Bio has secured an estimated £150k in its latest funding round. Founded in 2017 as a spin-out from the University ...

Reducing the incidence of skin cancer among men is the core mission of Dic Products Limited, which has just secured £45k in its latest funding round. The Epsom-based company focuses on the manufacture...

Manufacturing electronic components and medical instruments is the core focus of Frontier51 Ltd, which has just raised £150k in its latest funding round. Based in London, the company operates at the i...

Precision Microbubbles, a London-based medical equipment manufacturer, has raised £350k in a recent funding round. The investment values the company at an estimated £3.3m. Founded in July 2025, the c...

Developing antibody therapies to reverse amyloidosis is the core mission of Cambridge-based Immutrin, which has just closed a significant funding round. The biotechnology firm secured an estimated £19...

Research and manufacturing of cannabinoid-based pharmaceutical medicines (CBPMs) is the core focus of 113 Botanicals Limited, which has recently secured an estimated £220k in new funding. Based in Sou...

Improving patient outcomes through the distribution of eye health supplements across African markets is the core mission of Envision Pharma Group Limited, which has just raised an estimated £614k. Bas...

Synthetic T cell-priming vaccines and immunotherapies are being developed by Gylden Pharma Limited to combat viral and bacterial infectious diseases. The Abingdon-based biotechnology company recently ...

Veterinary care services provided through a membership model are the core offering of Petcarecollective Ltd, which trades as Pickles Vets. The London-based company has raised an estimated £110.9k in a...

Uniq Health Ltd has secured £100.1k in a new funding round to support its personalized healthcare platform for women. Trading under the name Tuune, the Cambridge-based company specializes in hormonal ...

Draig Therapeutics has secured an estimated £34.6m in a Series A funding round to advance its pipeline of next-generation neuromodulators. The Cardiff-based clinical-stage biotechnology company focuse...

Cardiaza, a patented epigenetic modifying therapy designed to treat symptomatic hypertrophic cardiomyopathy, is the primary focus of Belfast-based Signacor Therapeutics Limited following its latest fu...

The fuseAware safety system, a technology solution for tracking and managing on-site health and safety, has received fresh backing as its parent company Fuseaware Limited raised an estimated £384.8k. ...

Automating the production of precision medicines is the core focus of Microfluidx Ltd, which has raised an estimated £135.7k in its latest funding round. Based in Stevenage, the company develops the C...

Structuring data from Electronic Health Records for private clinics is the core focus of Nudge Care Ltd, which has secured £136.2k in new funding. This investment values the London-based startup at an...

Wearable ultrasound devices designed to non-invasively interface with the brain are the focus of a £1.2m funding round for Neuroharmonics Ltd. The London-based company is developing a neurotechnology ...

Turbine Simulated Cell Technologies Ltd develops an AI-driven Simulated Cell platform that creates digital twins of human cells to conduct virtual experiments for drug discovery and development. Based...

Lower-limb amputees can access faster prosthetic fittings through the Amparo System, a remoldable socket technology developed by High Wycombe-based Amparo Prosthetics Ltd. The company has secured an e...

Developing patented drug delivery patches to treat chronic wounds, Ebbw Vale-based Onya Therapeutics has raised an estimated £4609.9m in its latest funding round. This Series C+ investment brings the ...

A first-in-class small molecule anti-fibrinolytic treatment for traumatic haemorrhage is being developed by Clotprotect Therapeutics Limited following an estimated £600k seed funding round. The Leeds-...

AI-driven computer vision algorithms developed by Vet Vision Ai Limited are the focus of a new seed funding round estimated at £494.1k. Based in Belper, the company is a spin-out from the University o...

TalentFind, a recruitment platform designed to connect healthcare professionals with hospital recruiters, is the core product of London-based Ohr Recruitment Ltd. The company recently secured an estim...

Applying neuroscience and machine learning to banking security, Kalgera Limited has raised an estimated £144.5k in new funding. The King's Cross based company reached an estimated post-money valuation...

Developing a proprietary platform for red blood cell-based therapeutics, Bristol-based Scarlet Therapeutics has secured an estimated £3.5m in its latest funding round. The company generates novel ther...

Digitizing the sense of smell through AI-powered sensors is the core mission of Anemo Labs Limited, which has just raised an estimated £455k. Based in London, the biotechnology research company is dev...